SKI Market

Indian Indices

Sensex

83,333.75 519.04
( 0.63%)

Global Indices

Nasdaq

49,649.56 233.39
(0.47%)

Dow Jones

6,930.29 47.40
(0.69%)

Hang Seng

56,838.27 -629.56
(-1.10%)

Nikkei 225

10,691.66 64.62
(0.61%)

Forex

USD-INR

91.03 0.34
(0.37%)

EUR-INR

107.23 0.00
(0.00%)

GBP-INR

122.67 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.25%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

242.5445604

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

35.48

12851.68

EPS(TTM)

Face Value()

Div & Yield %

47.66

0.35

Back

Balkrishna Industries consolidated net profit declines 14.98% in the December 2025 quarter

Jan 29,2026

Net profit of Balkrishna Industries declined 14.98% to Rs 382.15 crore in the quarter ended December 2025 as against Rs 449.48 crore during the previous quarter ended December 2024. Sales rose 6.89% to Rs 2736.79 crore in the quarter ended December 2025 as against Rs 2560.33 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2736.79	2560.33	7
OPM %	23.50	23.46	-
PBDT	686.40	772.27	-11
PBT	491.06	599.68	-18
NP	382.15	449.48	-15

83,333.75 519.04 ( 0.63%)

49,649.56 233.39 (0.47%)

6,930.29 47.40 (0.69%)

56,838.27 -629.56 (-1.10%)

10,691.66 64.62 (0.61%)

91.03 0.34 (0.37%)

107.23 0.00 (0.00%)

122.67 -0.16 (-0.13%)

0.59 0.00 (-0.25%)